• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Siobhan P. Lynch, Yu Shen, Ashish Kamat, et al. neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.020.

作者信息

Ismaili Nabil

出版信息

Eur Urol. 2012 Sep;62(3):e65-6. doi: 10.1016/j.eururo.2012.05.061. Epub 2012 Jun 5.

DOI:10.1016/j.eururo.2012.05.061
PMID:22682991
Abstract
摘要

相似文献

1
Re: Siobhan P. Lynch, Yu Shen, Ashish Kamat, et al. neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.020.
Eur Urol. 2012 Sep;62(3):e65-6. doi: 10.1016/j.eururo.2012.05.061. Epub 2012 Jun 5.
2
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.小细胞尿路上皮癌的新辅助化疗可改善病理降期和长期预后：MD 安德森癌症中心回顾性研究的结果。
Eur Urol. 2013 Aug;64(2):307-13. doi: 10.1016/j.eururo.2012.04.020. Epub 2012 Apr 17.
3
Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.病理降期是新辅助化疗和根治性膀胱切除术治疗肌层浸润性尿路上皮膀胱癌后疗效和生存率提高的替代标志物。
Eur Urol. 2012 Jun;61(6):1229-38. doi: 10.1016/j.eururo.2011.12.010. Epub 2011 Dec 13.
4
[Small cell carcinoma of the urinary bladder: a case report].[膀胱小细胞癌：一例报告]
Hinyokika Kiyo. 2000 Jul;46(7):475-7.
5
Neoadjuvant chemotherapy in patients with invasive bladder cancer.浸润性膀胱癌患者的新辅助化疗
Urol Clin North Am. 2005 May;32(2):231-7. doi: 10.1016/j.ucl.2005.03.001.
6
Re: Evanguelos Xylinas, Michael Rink, Eugene K. Cha, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.052.回复：埃万盖洛斯·克西利纳斯、迈克尔·林克、尤金·K·查等人。远端输尿管处理对上尿路尿路上皮癌根治性肾输尿管切除术后肿瘤学结局的影响。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2012.04.052 。
Eur Urol. 2012 Nov;62(5):e92-3. doi: 10.1016/j.eururo.2012.07.046. Epub 2012 Jul 31.
7
Re: Beat Roth, Frédéric D. Birkhäuser, Pascal Zehnder, et al. Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.05.052.回复：《击败罗斯》，弗雷德里克·D·伯克豪泽、帕斯卡·策恩德等著。肠外营养不能改善根治性膀胱切除术后的恢复：一项前瞻性随机试验的结果。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2012.05.052
Eur Urol. 2012 Oct;62(4):e79; author reply e80. doi: 10.1016/j.eururo.2012.07.001. Epub 2012 Jul 13.
8
Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.回复：弗洛里斯·H·格罗嫩迪克、杰罗恩·德容、伊丽莎白·E·弗兰森·范德普特等。ERBB2突变特征为一组对新辅助化疗有极佳反应的肌层浸润性膀胱癌。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2015.01.014 。
Eur Urol. 2015 Aug;68(2):e31-2. doi: 10.1016/j.eururo.2015.02.044. Epub 2015 Mar 12.
9
Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23.作者对Axel Heidenreich的反驳：膀胱肌层浸润性尿路上皮癌：新辅助化疗使精心挑选的患者能够接受保留器官治疗。《欧洲泌尿外科杂志》2008年；54卷：21 - 23页
Eur Urol. 2008 Jul;54(1):23-4. doi: 10.1016/j.eururo.2008.01.053. Epub 2008 Jan 28.
10
Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.回复埃利泽·M·范·艾伦、利瓦伊·A·加拉韦和乔纳森·E·罗森伯格致编辑的信，信的内容涉及弗洛里斯·H·格罗嫩迪克、杰罗恩·德容、伊丽莎白·E·弗兰森·范·德·普特等人的文章：《ERBB2突变特征定义了一组对新辅助化疗有良好反应的肌层浸润性膀胱癌》。《欧洲泌尿外科杂志》即将发表。http://dx.doi.org/10.1016/j.eururo.2015.01.014 。
Eur Urol. 2015 Aug;68(2):e33-4. doi: 10.1016/j.eururo.2015.02.043. Epub 2015 Mar 13.